Ivermectin Joins Health Insurance Talks as Premiums Set to Soar
The U.S. healthcare system is once again in the spotlight as Americans brace for rising insurance premiums in 2025. With Affordable Care Act (ACA) subsidies set to change, employer costs climbing, and debates over pharmaceutical coverage intensifying, one drug has resurfaced in public and policy discussions: Ivermectin. Once primarily known for treating parasitic infections, ivermectin […]